GLP-2 TZ

GLP-2 TZ is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. In research, it is studied for its ability to improve glycemic control, promote significant weight reduction, and regulate appetite through enhanced insulin secretion and reduced glucagon activity.

It has been investigated for applications in obesity management, type 2 diabetes research, and metabolic health. By activating both GIP and GLP-1 pathways, TZ enhances insulin sensitivity, lowers blood glucose levels, and supports weight loss through appetite regulation and improved energy metabolism.

Key Benefits:

• Supports research on glucose regulation and insulin sensitivity.
• Aids studies on weight loss, appetite control, and obesity management.
• Contributes to research on type 2 diabetes and metabolic syndrome.
• Promotes fat reduction and improved body composition.
• Explored for roles in cardiovascular and metabolic health.

Purity Assurance

Every peptide we offer undergoes rigorous testing to ensure research-grade purity. Our claims are backed by regular in-house & third-party batch testing, assuring the highest quality standards.

This product is for research purposes only. It is intended exclusively for in vitro testing and laboratory experiments. All information provided on this website is for educational purposes and is not intended for human or animal use. The introduction of this product into the body, whether by ingestion, injection, or any other means, is strictly prohibited by law. Only licensed and qualified professionals should handle this product. It is not a drug, food, or cosmetic and must not be mislabeled, misused, or marketed as such.